UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:January 18,
Addex Therapeutics (NASDAQ:ADXN)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Addex Therapeutics Charts.
Addex Therapeutics (NASDAQ:ADXN)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Addex Therapeutics Charts.

Addex Therapeutics Ltd. News

Addex Provides Update on ADX71149 Phase 2 Epilepsy Study
Monday 29 April 2024 (1 week ago) • GlobeNewswire Inc.
Addex to Present at the Swiss Biotech Day 2024
Friday 19 April 2024 (3 weeks ago) • GlobeNewswire Inc.
Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update
Thursday 18 April 2024 (3 weeks ago) • GlobeNewswire Inc.
Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024
Thursday 11 April 2024 (4 weeks ago) • GlobeNewswire Inc.
Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders
Wednesday 3 April 2024 (1 month ago) • GlobeNewswire Inc.
Addex to Present at the Bio-Europe Spring 2024 Conference
Thursday 14 March 2024 (2 months ago) • GlobeNewswire Inc.
Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.
Wednesday 31 January 2024 (3 months ago) • GlobeNewswire Inc.
Form 424B5 - Prospectus [Rule 424(b)(5)]
Tuesday 30 January 2024 (3 months ago) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 30 January 2024 (3 months ago) • Edgar (US Regulatory)
Addex to Present at the Swiss Equities Baader Conference
Tuesday 9 January 2024 (4 months ago) • GlobeNewswire Inc.
Addex to Present at Biotech Showcase™ 2024
Friday 5 January 2024 (4 months ago) • GlobeNewswire Inc.
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
Thursday 21 December 2023 (5 months ago) • Edgar (US Regulatory)

More Addex Therapeutics Ltd. News Articles